HealthPartners opens enrollment for 1,500 people in COVID-19 vaccine trial

HealthPartners announced Wednesday that it will be enrolling at least 1,500 people in a clinical trial that will determine whether a vaccine developed by Oxford University researchers is effective at preventing COVID-19.